More Cells. Less Hassle.

More Cells. Less Hassle.

Satisfied Surgeon.

Satisfied Surgeon.

Offer your surgeons trusted technology with
the DirectCell® System.

Offer your surgeons trusted technology with the DirectCell® System.

The science-backed solution that provides spin-free live cell
harvesting, plus a premium bioactive synthetic – all in one
advanced system.*

The science-backed solution that provides spin-free live cell harvesting, plus a premium bioactive synthetic – all in one advanced system.

The science-backed solution that provides spin-free live cell harvesting, plus a premium bioactive synthetic – all in one advanced system.

Contact to Learn More

More Cells. In Less Time. With No Spin

Maximize stem cell collection with a closed-tip cell harvester that enables efficient and precise marrow harvesting, while minimizing collection of peripheral blood.

Cells can also be harvested percutaneously via marrow rich autograft dowels.

No centrifuging required.

Contact to Learn More

See how the DirectCell System compares:

See how the DirectCell System compares:

Stem Cell Chart

Bioactive Graft, Packed to Perform*

TrelCor’s® nanocrystalline HCA surface technology goes to work immediately upon implantation, stimulating cellular healing.1,2

Contact to Learn More

Superior Handling and Seamless Blending

Stem cells collected through autograft or marrow harvest will blend seamlessly with Agilon® bioactive bone grafts.*

Agilon bone grafts are densely packed with cell-stimulating granules to maximize contact with bone upon implantation.1,2

Contact to Learn More
Broaden your portfolio and offer your surgeons trusted technology with the

DirectCell Advanced Bone Grafting System.

DirectCell Advanced Bone Grafting System.

Have a question about the
DirectCell System?
Have a question about the DirectCell System?
Contact Us
TEXT “CELL” TO
833-231-3791
Trusted experts in bone regeneration.

References:

  1. Zhang J. et al. J. of Tissue Eng. And Regen. Med. 11: pp 3273-3283 (2017).
  2. Hayashi K. et al. Materials Today Bio. 4: pp. 1-11 (2019).
  3. Scarpone J. et al. “Isolation of Clinically Relevant Concentrations of Bone Marrow Mesenchymal Stem Cells Without Centrifugation.” Journal of Translational Medicine vol. 17(1), 10 (2019). 
  4. Harrell D. (2016). Novel Technology to Increase Concentrations of Stem and Progenitor Cells in Marrow Aspiration [White paper]. Retrieved from Aspire Medical Innovations:
    https://aspire-medical.eu/marrowcellution/harrell-purita-update-white-paper/
  5. Hedge V. et al. “A Prospective Comparison of 3 Approved Systems for Autologous Bone Marrow Concentration Demonstrated Nonequivalency in Progenitor Cell Number and Concentration.” Journal of Orthopaedic Trauma, vol. 28(10): pp. 591–598 (2014).
  6. Brown LS. Darmoc MM, Clineff TD Investigation of Mesenchymal Stem Cell Phenotype and Function in an Allograft Cellular Bone Matrix. Stryker Corp. Malvern. PA (2013).
  7. McLain R, et al. J Bone Joint Surg Am. 87(12):2655-61 (2005).

* Data on file.

Back To Top